Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment

By Llaverias Gemma   Pou Jordi   Ros Emilio   Zambóón Daniel   Cofáán Montserrat   Sáánchez Alex   Váázquez-Carrera Manuel   Sáánchez Rosa M   Laguna Juan C   Alegret Marta  

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 1035-1054

Future Medicine

Access to resources Recommend Favorite

Current Status of CETP Inhibitors in the Treatment of Hyperlipidemia: An Update

By  

Current Clinical Pharmacology, Vol. 7, Iss. 2, 2012-01 ,pp. : 102-110

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple Lipid-lowering Treatment in Pediatric Patients with Hyperlipidemia

By  

Medicinal Chemistry, Vol. 8, Iss. 6, 2012-11 ,pp. : 1171-1181

Bentham Science Publishers

Access to resources Recommend Favorite

Should Pediatric Patients with Hyperlipidemia Receive Drug Therapy?

By Bhatnagar D.  

Pediatric Drugs, Vol. 4, Iss. 4, 2002-01 ,pp. : 223-230

Adis International

Access to resources Recommend Favorite

Efficacy of combination of atorvastatin and micronised fenofibrate in the treatment of severe mixed hyperlipidemia

By Kiortsis D.N.   Millionis H.   Bairaktari E.   Elisaf M.S.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 631-635

Springer Publishing Company

Access to resources Recommend Favorite